237 related articles for article (PubMed ID: 23159776)
1. Poly(ADP-ribose) polymerase inhibition prevents reactive oxygen species induced inhibition of aldehyde dehydrogenase2 activity.
Wei SJ; Xing JH; Wang BL; Xue L; Wang JL; Li R; Qin WD; Wang J; Wang XP; Zhang MX; Chen YG
Biochim Biophys Acta; 2013 Mar; 1833(3):479-86. PubMed ID: 23159776
[TBL] [Abstract][Full Text] [Related]
2. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation.
He L; Liu B; Dai Z; Zhang HF; Zhang YS; Luo XJ; Ma QL; Peng J
Eur J Pharmacol; 2012 Mar; 678(1-3):32-8. PubMed ID: 22266491
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
Kaplan J; O'Connor M; Hake PW; Zingarelli B
Shock; 2005 Mar; 23(3):233-8. PubMed ID: 15718920
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial aldehyde dehydrogenase, a potential drug target for protection of heart and brain from ischemia/reperfusion injury.
Luo XJ; Liu B; Ma QL; Peng J
Curr Drug Targets; 2014; 15(10):948-55. PubMed ID: 25163552
[TBL] [Abstract][Full Text] [Related]
5. BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase.
Szabados E; Literati-Nagy P; Farkas B; Sumegi B
Biochem Pharmacol; 2000 Apr; 59(8):937-45. PubMed ID: 10692558
[TBL] [Abstract][Full Text] [Related]
6. Acetylation-dependent regulation of mitochondrial ALDH2 activation by SIRT3 mediates acute ethanol-induced eNOS activation.
Xue L; Xu F; Meng L; Wei S; Wang J; Hao P; Bian Y; Zhang Y; Chen Y
FEBS Lett; 2012 Jan; 586(2):137-42. PubMed ID: 22155639
[TBL] [Abstract][Full Text] [Related]
7. Enhanced ADP-ribosylation and its diminution by lipoamide after ischemia-reperfusion in perfused rat heart.
Szabados E; Fischer GM; Gallyas F; Kispal G; Sumegi B
Free Radic Biol Med; 1999 Nov; 27(9-10):1103-13. PubMed ID: 10569643
[TBL] [Abstract][Full Text] [Related]
8. [Poly (ADP-ribose) polymerase inhibition attenuates ischemia/reperfusion induced myocardial injury in rat via reducing myocardial nuclear factor κB activity].
Song ZF; DU B; Ji XP
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):997-1002. PubMed ID: 23363712
[TBL] [Abstract][Full Text] [Related]
9. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-Ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite.
Radovits T; Zotkina J; Lin LN; Bömicke T; Arif R; Gerö D; Horváth EM; Karck M; Szabó C; Szabó G
Exp Biol Med (Maywood); 2007 Oct; 232(9):1204-12. PubMed ID: 17895528
[TBL] [Abstract][Full Text] [Related]
11. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
12. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress.
Zhang T; Zhao Q; Ye F; Huang CY; Chen WM; Huang WQ
Free Radic Res; 2018 Jun; 52(6):629-638. PubMed ID: 29589772
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of poly(ADP-ribose) polymerase attenuates lung tissue damage after hind limb ischemia-reperfusion in rats.
Koksel O; Yildirim C; Cinel L; Tamer L; Ozdulger A; Bastürk M; Degirmenci U; Kanik A; Cinel I
Pharmacol Res; 2005 May; 51(5):453-62. PubMed ID: 15749460
[TBL] [Abstract][Full Text] [Related]
14. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
Tao R; Kim SH; Honbo N; Karliner JS; Alano CC
J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
[TBL] [Abstract][Full Text] [Related]
15. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury.
Cuzzocrea S; Reiter RJ
Eur J Pharmacol; 2001 Aug; 426(1-2):1-10. PubMed ID: 11525764
[TBL] [Abstract][Full Text] [Related]
17. Poly (ADP-ribose) polymerase inhibition protects against myocardial ischaemia/reperfusion injury via suppressing mitophagy.
Cao S; Sun Y; Wang W; Wang B; Zhang Q; Pan C; Yuan Q; Xu F; Wei S; Chen Y
J Cell Mol Med; 2019 Oct; 23(10):6897-6906. PubMed ID: 31379115
[TBL] [Abstract][Full Text] [Related]
18. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
[TBL] [Abstract][Full Text] [Related]
19. Remote Ischemic Conditioning Mediates Cardio-protection After Myocardial Ischemia/Reperfusion Injury by Reducing 4-HNE Levels and Regulating Autophagy via the ALDH2/SIRT3/HIF1α Signaling Pathway.
Gao R; Lv C; Qu Y; Yang H; Hao C; Sun X; Hu X; Yang Y; Tang Y
J Cardiovasc Transl Res; 2024 Feb; 17(1):169-182. PubMed ID: 36745288
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of 5-aminoisoquinolinone, a novel, potent, water-soluble, inhibitor of poly (ADP-ribose) polymerase, in a rat model of splanchnic artery occlusion and reperfusion.
Di Paola R; Genovese T; Caputi AP; Threadgill M; Thiemermann C; Cuzzocrea S
Eur J Pharmacol; 2004 May; 492(2-3):203-10. PubMed ID: 15178366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
